The brand frames this as the gentlest starting point, useful either as a first GLP-1 protocol for buyers worried about side effects, or as a maintenance tier for buyers stepping down after reaching a target weight on a full-dose protocol
Furthermore, hospital pharmacies often manage the dispensing of injectable medications requiring specific storage and handling, which is the case for many GLP-1 receptor agonists
In obese rats, GEP44 produced greater weight loss than exendin-4, an older GLP-1 drug, while nearly eliminating vomiting-related behaviors
Factors such as: Degree of insulin resistance Presence of other conditions (cardiovascular disease, fatty liver disease, sleep apnoea) Family history of diabetes or obesity Age and menopausal status Previous weight loss attempts and patterns of weight regain Safety considerations and tolerability play an important role
The tirzepatide dosing in units guide covers the full escalation protocol